Today: 9 June 2026
Rolls-Royce share price dips early as buyback updates land and SMR deal adds a new angle
21 January 2026
1 min read

Rolls-Royce share price dips early as buyback updates land and SMR deal adds a new angle

London, Jan 21, 2026, 08:17 GMT — Regular session.

Shares of Rolls-Royce Holdings (RR.L) dipped roughly 1.1% in early London trading Wednesday, hitting 1,266.5 pence after closing at 1,281 pence the day before. Despite the drop, the stock remains up about 10% year-to-date.

The dip catches attention as investors balance two key factors: ongoing share buybacks and new developments in the group’s small nuclear reactor initiative.

Rolls-Royce has been cutting its share count through buybacks, a way to return capital to shareholders by repurchasing its own stock. Meanwhile, updates from its SMR venture are coming more often as the company seeks partners and pushes from design into delivery stages.

U.S. engineering firm Amentum announced Tuesday it’s been named program delivery partner for the initial rollout of Rolls-Royce’s Small Modular Reactor (SMR) — a compact nuclear plant designed for factory construction and on-site assembly. Chris Cholerton, CEO of Rolls-Royce SMR, said the collaboration will “enable successful delivery on our order commitments in multiple markets.” Amentum CEO John Heller described the move as a boost to energy security across Britain and Europe. Amentum

Rolls-Royce revealed another round of buybacks on Wednesday, acquiring 389,819 ordinary shares on the London Stock Exchange on Jan. 20. It also snapped up smaller amounts on other platforms, with a volume-weighted average price of roughly 1,254 pence on the LSE. The company plans to cancel these shares, leaving 8,396,218,633 shares outstanding after the deal.

The previous day, the company disclosed buying 423,778 shares on the LSE on Jan. 19, alongside purchases on other exchanges. The average price on the main venue hovered around 1,278 pence.

The repurchases form part of a £200 million interim buyback scheme announced last December. Rolls-Royce said the plan was arranged ahead of its full-year 2025 results announcement, adding that any buybacks in 2026 will depend on board approval.

Traders often see buybacks as a signal of a company’s cash confidence. Yet, they can slip out of focus when valuations run high or investors hold out for more significant catalysts.

Risks remain. The SMR segment is a long game, loaded with execution challenges, making revenue timing less predictable than the company’s main aerospace and defence operations. Buybacks can also taper off fast if cash flow falls short or if management rethinks the value of repurchasing shares.

Investors are now turning to daily buyback reports to track the pace and pricing, with full-year 2025 results due Feb. 26 expected to shed light on 2026 capital returns.

Stock Market Today

  • Pro Portfolio Adds Broadcom and Netflix Shares, Upgrades Broadcom Rating
    June 9, 2026, 10:19 AM EDT. The Pro Portfolio is buying 80 shares of Broadcom (AVGO) at around $405, increasing its holdings to 512 shares (3.4% of the portfolio). It is also purchasing 372 shares of Netflix (NFLX) near $82.35, increasing its stake to 2,107 shares (2.85%). Broadcom's AI chip forecast for H2 2026 is viewed as conservative following a $35 billion private credit deal involving Apollo and Blackstone. The rating for Broadcom is upgraded to One, with a checkpoint price of $330 maintained. Netflix's shares are seen as undervalued despite recent declines, supported by a $25 billion buyback and rising U.S. viewership. Netflix's ad business shows growth potential, reaching 250 million monthly active viewers, reinforcing optimism amidst concerns over consumer spending.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
BP share price today: BP stock edges up after buyback update as oil prices slip
Previous Story

BP share price today: BP stock edges up after buyback update as oil prices slip

Lloyds share price drops 1.6% in early London trade as inflation data lands, tariffs rattle banks
Next Story

Lloyds share price drops 1.6% in early London trade as inflation data lands, tariffs rattle banks

Go toTop